Archive for October, 2019
Standardising DRG (Diagnosis Related Groups) payment
On October 23rd, the National Medical Insurance Bureau issued the “Notification on Technical Specifications and Grouping Plans of Pilot Works of DRG Payment” including the “Technical Specifications of DRG Grouping and Payment” and “Grouping Plans of DRG(CHS-DRG) Payment.” The “Notification” stipulated that because the CHS-DRG covers nearly all treatments of diseases, it will become the only standard for DRG payment implemented by the National Medical Insurance. In addition, pilot cities of DRG payment should execute the “Grouping Plan” and formulate local subdivided DRGs according to the unified guidelines of grouping and the actual situation of each city.
国家医保局发文 DRG付费标准正式走向统一
来源： 医药网 2019.10.25
10月23日，国家医保局正式公布《关于疾病诊断相关分组（DRG）付费国家试点技术规范和分组方案的通知》，包含《国家医疗保障DRG分组与付费技术规范》和《国家医疗保障DRG（CHS-DRG）分组方案》。《通知》指出，CHS-DRG可基本实现疾病治疗全覆盖，将成为全国医保部门实行DRG付费的唯一标准；各试点城市应严格执行《分组方案》，按照统一的分组操作指南，并结合各地实际情况制定本地的细分DRG分组。
Improving the supply system of shortage medicines
Recently, the General Office of the State Council issued the “Guiding Opinions on Maintaining the Price and Supply of Shortage Medicines.” The “Guiding Opinion” stipulated that a national multi-source information collection platform for shortage medicines and a monitoring system for this platform should be established to realise information sharing of APIs (Active Pharmaceutical Ingredient) and pharmaceutical preparations in terms of their registration, production, procurement, and price. As for the drugs in the shortages list, pharmaceutical enterprises are allowed to quote their price on the provincial-level centralised drug procurement platform or on the internet so that medical institutions can purchase them on demand.
国办：强化药品价格常态化监管 完善短缺药品供应体系
来源：医药网 2019.10.14
近日，国务院办公厅印发《关于进一步做好短缺药品保供稳价工作的意见》（以下简称《意见》）。《意见》指出，应建立国家短缺药品多源信息采集平台和协同监测机制，实现原料药和制剂在注册、生产、采购、价格等方面的信息联通共享；对于短缺药品清单中的品种，允许企业在省级药品集中采购平台上自主报价、直接挂网，医疗机构自主采购。